## DD: DuPont de Nemours, Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 0.7% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($38.70)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Jim Cramer Says "Do Not Sell DuPont (DD)"**
- Source: Finviz | 20251218T001018 | Bullish | Relevance: 100%
- Jim Cramer advises against selling DuPont (DD) despite the Qnity Electronics spinoff and an upcoming dividend reduction, citing the strong leadership of Lori Koch and the excellent performance of its water and materials businesses. He believes in the company's story, particularly the value proposition of the Qnity spinoff and the potential for Executive Chairman Ed Breen to unlock further value, even while acknowledging challenges without rate cuts. Cramer's Charitable Trust also holds DuPont stock.

**2. Jim Cramer Says “Do Not Sell DuPont (DD)”**
- Source: Yahoo Finance Singapore | 20251217T173157 | Bullish | Relevance: 100%
- Jim Cramer strongly advises against selling DuPont (DD) stock, despite a recent spinoff and upcoming dividend reduction. He highlights the company's strong properties, excellent water business, and materials, praising CEO Lori Koch's leadership. Cramer believes in the company's ability to extract value, referencing the Qnity Electronics spinoff as a positive development.

**3. Jim Cramer Says “Do Not Sell DuPont (DD)”**
- Source: Insider Monkey | 20251217T122900 | Bullish | Relevance: 100%
- Jim Cramer recommends holding DuPont (DD) despite the recent Qnity Electronics spinoff and a planned dividend reduction, citing the company's strong properties and leadership. He expresses optimism for the Qnity spinoff, especially given the AI boom, and believes DuPont itself is currently undervalued. Cramer suggests that while rate cuts would help DuPont's targets, Executive Chairman Ed Breen can unlock significant value.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Mizuho | $46 | $44 | +5% |
| 2025-11-18 | RBC Capital | $48 | $100 | -52% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Mizuho | main | Outperform |
| 2025-11-18 | RBC Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 11 ($0.27M) |
| Sells | 2 ($0.22M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+6.7%)
- Blackrock Inc.: 7.6% (-5.1%)
- State Street Corpora: 4.3% (-0.9%)
- Geode Capital Manage: 2.6% (+1.5%)
- Nuveen, LLC: 2.1% (+7.4%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-1.8% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.78 indicates undervaluation relative to growth. Forward P/E 18.8x attractive for 25% earnings growth. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.0B |
| Beta | 1.14 |
| 52W Range | $22.50 - $41.83 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.78 |
| Forward P/E | 18.8 |
| Current P/E | 23.5 |
| YoY Growth | 24.8% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 2.5% to 0.7% (-1.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.3pp (needs >3.0% for momentum thesis). MRS_5 (-0.2%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -MUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.74% (CS: 46) | Neutral |
| RSI_14 | 60.5 | Neutral |
| MACD Histogram | -0.14 | Bearish |
| vs SMA20 | 1.015x | Above |
| vs SMA50 | 1.082x | Above |
| vs SMA200 | 1.271x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $40.52
- **Stop Loss:** $38.70 (4.5% risk)
- **Target:** $42.34 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 626
- **Position Value:** $25,365.52
- **Portfolio %:** 25.37%
- **Risk Dollars:** $1,140.00
- **Risk Per Trade:** 1.14%
- **Modifiers:** L1 95% | L2 120% | Combined 1.14x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-10 (Est: $0.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.98 | $1.09 | +11.2% |
| 2025Q2 | $1.06 | $1.12 | +5.5% |
| 2025Q1 | $0.95 | $1.03 | +8.1% |
| 2024Q4 | $0.98 | $1.13 | +15.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*